시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 인간 1차 세포 배양 시장 보고서(2025년)
Human Primary Cell Culture Global Market Report 2025
상품코드 : 1751021
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,521,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,426,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,330,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

인간 1차 세포 배양 시장 규모는 향후 수 년간 급성장이 전망될 예정입니다. 예측 기간 동안의 성장은 재생 의학에 대한 투자 증가, 정밀 의학 사용 증가, 세포 기반 연구를 위한 정부 자금 증가, 정부 지원 강화, 독성학 검사에서 인간 1차 세포 배양의 확대에 기인할 수 있습니다. 예측 기간 중에 예상되는 주요 동향에는 세포 배양 분석에 있어서의 인공지능(AI)의 통합, 무혈청 배지나 화학적으로 정의된 배지의 개발, 세포 배양 프로세스의 자동화의 진전, organ-on-a-chip 기술의 출현, 면역요법 연구에 있어서의 초대 세포 수요 증가 등이 있습니다.

세포요법과 유전자요법에 대한 주목의 고조가 인간 1차 세포 배양 시장의 확대를 견인할 것으로 예측되고 있습니다. 이러한 관심이 높아지고 있는 배경에는 유전성 질환, 희귀질환, 암 등의 근본적인 원인을 타겟으로 하는 것으로, 장기간에 걸쳐, 혹은 근치적인 해결책을 제공하는 것이 기대되고 있는 일이 있습니다. 인간 1차 세포 배양은 이러한 치료법의 개발, 바이러스 벡터의 제조, 유전자 편집 접근법의 시험에 중요한 역할을 하고 있습니다. 2024년 7월, 미국에 본사를 둔 비영리 단체인 미국 유전자 및 세포 치료 학회(ASGCT)는 2024년 2분기에 미국에서 76건의 유전자 치료 시험이 1분기에 비해 25% 증가했다고 보고했습니다. 그 결과 세포요법과 유전자요법에 대한 주목이 높아져 인간 1차 세포 배양 시장의 성장이 가속화되고 있습니다.

iPS 세포와 ESC 기술은 성체 세포와 배아 세포를 다능성 상태로 초기화함으로써 과학 연구, 치료 개발, 질병 모델링에 사용하는 다양한 세포 유형으로 분화를 가능하게 합니다. 2024년 7월, 인도에 본사를 둔 생명과학 및 생명공학 회사인 BioServe Biotechnologies India Pvt Ltd.는 인도에서 연구 및 신약 개발을 지원하기 위해 REPOCELL의 새로운 첨단 줄기세포 제품군을 출시했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Human primary cell culture refers to the process of isolating cells directly from human tissues such as blood or bone marrow and maintaining them in a controlled environment for research or therapeutic use. These cultures offer a more accurate reflection of in vivo biological conditions compared to immortalized cell lines, making them highly valuable for scientific and medical applications.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main product types in human primary cell culture include primary cells, reagents and supplements, instruments, primary cell culture media, and other related products. Primary cells are directly extracted from living tissues and are commonly used in research, drug testing, and various medical studies. Applications of human primary cell culture span drug discovery, therapy development, regenerative medicine, and more. These products and technologies serve a diverse range of end users, including pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic and research institutions.

The human primary cell culture market research report is one of a series of new reports from The Business Research Company that provides human primary cell culture market statistics, including human primary cell culture industry global market size, regional shares, competitors with a human primary cell culture market share, detailed human primary cell culture market segments, market trends and opportunities, and any further data you may need to thrive in the human primary cell culture industry. This human primary cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human primary cell culture market size has grown rapidly in recent years. It will grow from $3.39 billion in 2024 to $3.79 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period can be attributed to the increasing adoption of cell-based research, rising demand for personalized medicine, a growing emphasis on drug discovery, an enhanced focus on individualized treatment approaches, and the expanding applications of human primary cell culture in cancer research.

The human primary cell culture market size is expected to see rapid growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth during the forecast period can be attributed to rising investments in regenerative medicine, increased use in precision medicine, growing government funding for cell-based research, enhanced governmental support, and the expanding use of human primary cell culture in toxicology testing. Key trends anticipated in the forecast period include the integration of artificial intelligence (AI) in cell culture analysis, the development of serum-free and chemically defined media, increasing automation in cell culture processes, the emergence of organ-on-a-chip technology, and the growing demand for primary cells in immunotherapy research.

The rising emphasis on cell and gene therapies is anticipated to drive the expansion of the human primary cell culture market. Cell and gene therapies are cutting-edge treatments that involve modifying or replacing genetic material or cells to address diseases at their molecular roots. This growing interest is fueled by the promise of these therapies to offer long-lasting or even curative solutions for genetic disorders, rare diseases, and cancers by targeting their underlying causes. Human primary cell cultures play a vital role in developing these therapies, producing viral vectors, and testing gene-editing approaches. For example, in July 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based nonprofit organization, reported that 76 gene therapy trials were launched in the United States in Q2 2024 a 25% rise compared to the first quarter. As a result, the increasing focus on cell and gene therapies is accelerating the growth of the human primary cell culture market.

Leading companies in the human primary cell culture market are investing in the development of advanced technologies such as induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) to boost research capabilities, drug discovery, and regenerative medicine efforts. iPSC and ESC technologies involve reprogramming adult or embryonic cells into pluripotent states, enabling them to differentiate into various cell types for use in scientific research, therapy development, and disease modeling. For instance, in July 2024, BioServe Biotechnologies India Pvt Ltd., an India-based life sciences and biotechnology company, introduced a new range of advanced stem cell products from REPROCELL to support research and drug discovery in India. These offerings include specialized cell culture media, stem cell differentiation kits, 3D culture systems, and drug discovery tools advancing regenerative medicine and preclinical studies powered by iPSC and ESC innovations.

In April 2023, AnaBios Corporation, a US-based contract research organization (CRO), announced the acquisition of Cell Systems Corporation for an undisclosed sum. Through this acquisition, AnaBios seeks to broaden its portfolio of biologically relevant human tissues and primary cells, enhancing research capabilities in cell biology and drug discovery. Cell Systems Corporation, also based in the US, is a provider of human primary cells, specialized cell culture media, and related reagents.

Major players in the human primary cell culture market are Thermo Fisher Scientific Inc., Merck & Co. Inc., Lonza Group AG, STEMCELL Technologies Inc., American Type Culture Collection, PromoCell GmbH, Krishgen Biosystems Private Limited, Cell Culture Company Limited Liability Company, HiMedia Laboratories Private Limited, 3H Biomedical Aktiebolag, ScienCell Research Laboratories Inc., Cell Applications Incorporated, Life Technologies Private Limited, PELOBIOTECH Gesellschaft mit beschrankter Haftung, Amsbio Limited, AcceGen Biotechnology Limited Liability Company, Cell Biologics Incorporated, BI Biotech India Private Limited, Innoprot Sociedad Limitada, ZenBio Incorporated, Evercyte GmbH, Cell Systems Corporation, Cytion GmbH, Kosheeka Private Limited.

North America was the largest region in the human primary cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human primary cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human primary cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human primary cell culture market consists of revenues earned by entities by providing services such as cell isolation, culture media development, cryopreservation, cell characterization, and quality control testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The human primary cell culture market also includes sales of culture media, reagents, bioreactors, incubators, cell storage systems, and imaging systems used in regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Primary Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human primary cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for human primary cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human primary cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Human Primary Cell Culture Market Characteristics

3. Human Primary Cell Culture Market Trends And Strategies

4. Human Primary Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Primary Cell Culture Growth Analysis And Strategic Analysis Framework

6. Human Primary Cell Culture Market Segmentation

7. Human Primary Cell Culture Market Regional And Country Analysis

8. Asia-Pacific Human Primary Cell Culture Market

9. China Human Primary Cell Culture Market

10. India Human Primary Cell Culture Market

11. Japan Human Primary Cell Culture Market

12. Australia Human Primary Cell Culture Market

13. Indonesia Human Primary Cell Culture Market

14. South Korea Human Primary Cell Culture Market

15. Western Europe Human Primary Cell Culture Market

16. UK Human Primary Cell Culture Market

17. Germany Human Primary Cell Culture Market

18. France Human Primary Cell Culture Market

19. Italy Human Primary Cell Culture Market

20. Spain Human Primary Cell Culture Market

21. Eastern Europe Human Primary Cell Culture Market

22. Russia Human Primary Cell Culture Market

23. North America Human Primary Cell Culture Market

24. USA Human Primary Cell Culture Market

25. Canada Human Primary Cell Culture Market

26. South America Human Primary Cell Culture Market

27. Brazil Human Primary Cell Culture Market

28. Middle East Human Primary Cell Culture Market

29. Africa Human Primary Cell Culture Market

30. Human Primary Cell Culture Market Competitive Landscape And Company Profiles

31. Human Primary Cell Culture Market Other Major And Innovative Companies

32. Global Human Primary Cell Culture Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Primary Cell Culture Market

34. Recent Developments In The Human Primary Cell Culture Market

35. Human Primary Cell Culture Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기